home - NEWS - Notice
Notice
  • 11-06BEIGENE ANNOUNCES CLOSING OF GLOBAL...

    CAMBRIDGE, Mass. and BEIJING, China, Aug. 31, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced the closing of

    read more
  • 0611-2018
    BEIGENE ANNOUNCES CLOSING OF GLOBAL...

    CAMBRIDGE, Mass. and BEIJING, China, Aug. 31, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced the closing of